ARTA
BSTC

A.R.T. Advisors’s BioSpecifics Technologies Corp. BSTC Stock Holding History

A.R.T. Advisors’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,700
Closed -$206K – 1831
2016
Q4 		$206K Buy
+3,700
New +$178K 0.01% 1053
2016
Q3 		– Sell
-8,788
Closed -$350K – 1355
2016
Q2 		$350K Buy
8,788
+1,800
+26% +$65.9K 0.02% 918
2016
Q1 		$243K Buy
+6,988
New +$256K 0.01% 1111

Other funds holding BSTC

JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
ECP
Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

A.R.T. Advisors's BSTC Position: Q1 2017 in Review

A.R.T. Advisors sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2017, closing a stake of 3,700 shares — an estimated $206K sold.

A.R.T. Advisors first reported a position in BSTC in Q1 2016 and held it in 3 quarters. The position peaked at $350K in Q2 2016. 89 funds tracked by Wall St. Rank hold BSTC as of Q1 2017.

  • A.R.T. Advisors reported no remaining BioSpecifics Technologies Corp. position as of Q1 2017 after selling out during the quarter.
  • A.R.T. Advisors sold 3,700 BioSpecifics Technologies Corp. shares in Q1 2017, an estimated $206K.
  • A.R.T. Advisors first reported a position in BioSpecifics Technologies Corp. in Q1 2016 and held it in 3 quarters.
  • A.R.T. Advisors's BioSpecifics Technologies Corp. position peaked at $350K in Q2 2016.
  • 89 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2017.

Based on A.R.T. Advisors's 13F filing for Q1 2017, filed 15 May 2017.